U.S. Physical Therapy Gelecekteki Büyüme
Future kriter kontrolleri 3/6
U.S. Physical Therapy kazanç ve gelirinin sırasıyla yıllık 47.5% ve 7.3% oranında artması tahmin edilirken, EPS'nin yıllık 52.4% oranında büyümesi bekleniyor.
Anahtar bilgiler
47.5%
Kazanç büyüme oranı
52.36%
EPS büyüme oranı
| Healthcare kazanç büyümesi | 18.4% |
| Gelir büyüme oranı | 7.3% |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Good |
| Son güncelleme | 21 May 2026 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Seeking Alpha • 23h
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaAnaliz Makalesi • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analiz Makalesi • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analiz Makalesi • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analiz Makalesi • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analiz Makalesi • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Analiz Makalesi • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Analiz Makalesi • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Analiz Makalesi • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analiz Makalesi • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Analiz Makalesi • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Yeni Anlatı • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Analiz Makalesi • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analiz Makalesi • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analiz Makalesi • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analiz Makalesi • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Analiz Makalesi • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Analiz Makalesi • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analiz Makalesi • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Analiz Makalesi • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Analiz Makalesi • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analiz Makalesi • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analiz Makalesi • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Seeking Alpha • Oct 13
U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Summary USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, primarily through partnership models, are central to USPH's growth strategy. The company expanded into the IIP sector in 2017 and has made several acquisitions. The U.S. rehab market is projected to exceed $40 billion by 2025, driven by demographic trends like an aging population, rising obesity, and a focus on cost-effective healthcare. Physical therapy has demonstratedcost-effectiveness in patient care, significantly reducing hospitalization ratesand total treatment costs. USPH's current stock valuepresents a favorable entry point, especially with market misconceptions aboutGLP-1 adoption impacting the physical therapy industry. Read the full article on Seeking AlphaAnaliz Makalesi • Oct 13
Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2028 | 981 | 56 | N/A | N/A | 1 |
| 12/31/2027 | 896 | 72 | 83 | 108 | 7 |
| 12/31/2026 | 839 | 57 | 68 | 92 | 7 |
| 3/31/2026 | 788 | 8 | 67 | 84 | N/A |
| 12/31/2025 | 773 | 22 | 61 | 75 | N/A |
| 9/30/2025 | 751 | 36 | 57 | 70 | N/A |
| 6/30/2025 | 722 | 35 | 61 | 72 | N/A |
| 3/31/2025 | 692 | 33 | 56 | 66 | N/A |
| 12/31/2024 | 664 | 28 | 66 | 75 | N/A |
| 9/30/2024 | 639 | 14 | 73 | 82 | N/A |
| 6/30/2024 | 621 | 16 | 68 | 77 | N/A |
| 3/31/2024 | 606 | 18 | 66 | 75 | N/A |
| 12/31/2023 | 599 | 18 | 73 | 82 | N/A |
| 9/30/2023 | 585 | 24 | 64 | 72 | N/A |
| 6/30/2023 | 575 | 26 | 62 | 70 | N/A |
| 3/31/2023 | 564 | 28 | 50 | 58 | N/A |
| 12/31/2022 | 548 | 29 | 50 | 59 | N/A |
| 9/30/2022 | 536 | 39 | 48 | 57 | N/A |
| 6/30/2022 | 522 | 38 | 59 | 68 | N/A |
| 3/31/2022 | 509 | 37 | 61 | 70 | N/A |
| 12/31/2021 | 490 | 31 | 68 | 76 | N/A |
| 9/30/2021 | 477 | 31 | 78 | 86 | N/A |
| 6/30/2021 | 461 | 30 | 81 | 87 | N/A |
| 3/31/2021 | 418 | 32 | 95 | 101 | N/A |
| 12/31/2020 | 418 | 32 | 92 | 100 | N/A |
| 9/30/2020 | 423 | 30 | 82 | 91 | N/A |
| 6/30/2020 | 431 | 31 | 72 | 82 | N/A |
| 3/31/2020 | 473 | 29 | 55 | 65 | N/A |
| 12/31/2019 | 477 | 31 | N/A | 62 | N/A |
| 9/30/2019 | 472 | 30 | N/A | 65 | N/A |
| 6/30/2019 | 468 | 23 | N/A | 71 | N/A |
| 3/31/2019 | 457 | 18 | N/A | 71 | N/A |
| 12/31/2018 | 449 | 17 | N/A | 73 | N/A |
| 9/30/2018 | 442 | 18 | N/A | 70 | N/A |
| 6/30/2018 | 432 | 22 | N/A | 65 | N/A |
| 3/31/2018 | 421 | 21 | N/A | 58 | N/A |
| 12/31/2017 | 410 | 22 | N/A | 57 | N/A |
| 9/30/2017 | 392 | 20 | N/A | 53 | N/A |
| 6/30/2017 | 377 | 20 | N/A | 42 | N/A |
| 3/31/2017 | 363 | 21 | N/A | 51 | N/A |
| 12/31/2016 | 353 | 21 | N/A | 51 | N/A |
| 9/30/2016 | 348 | 20 | N/A | 48 | N/A |
| 6/30/2016 | 344 | 21 | N/A | 49 | N/A |
| 3/31/2016 | 337 | 21 | N/A | 49 | N/A |
| 12/31/2015 | 327 | 21 | N/A | 38 | N/A |
| 9/30/2015 | 320 | 21 | N/A | 45 | N/A |
| 6/30/2015 | 313 | 20 | N/A | 43 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: USPH 'nin tahmini kazanç büyümesi (yıllık 47.5% ) tasarruf oranının ( 3.5% ) üzerindedir.
Kazançlar ve Piyasa: USPH şirketinin kazançlarının (yıllık 47.5% ) US pazarından (yıllık 16.8% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: USPH şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.
Gelir ve Pazar: USPH şirketinin gelirinin (yıllık 7.3% ) US pazarından (yıllık 11.7% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Geliri: USPH şirketinin gelirinin (yıllık 7.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: USPH 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok
Büyüyen şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/22 07:18 |
| Gün Sonu Hisse Fiyatı | 2026/05/22 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
U.S. Physical Therapy, Inc. 15 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |